BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451-9. [PMID: 11889061 DOI: 10.1136/gut.50.4.451] [Cited by in Crossref: 174] [Cited by in F6Publishing: 176] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Oh DS, DeMeester SR. Pathophysiology and treatment of Barrett’s esophagus. World J Gastroenterol 2010; 16(30): 3762-3772 [PMID: 20698038 DOI: 10.3748/wjg.v16.i30.3762] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
2 Davern M, Donlon NE, Power R, Hayes C, King R, Dunne MR, Reynolds JV. The tumour immune microenvironment in oesophageal cancer. Br J Cancer 2021;125:479-94. [PMID: 33903730 DOI: 10.1038/s41416-021-01331-y] [Reference Citation Analysis]
3 Naito Y, Uchiyama K, Kuroda M, Takagi T, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T. Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats. J Gastroenterol. 2006;41:198-208. [PMID: 16699853 DOI: 10.1007/s00535-005-1742-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
4 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
5 Kong J, Sai H, Crissey MA, Jhala N, Falk GW, Ginsberg GG, Abrams JA, Nakagawa H, Wang K, Rustgi AK, Wang TC, Lynch JP. Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia. Oncotarget 2015;6:32980-3005. [PMID: 26460825 DOI: 10.18632/oncotarget.5431] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Shah A, Shibli F, Kitayama Y, Fass R. The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. J Clin Gastroenterol 2021;55:12-20. [PMID: 32909972 DOI: 10.1097/MCG.0000000000001419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li J, Chen XL, Shaker A, Oshima T, Shan J, Miwa H, Feng C, Zhang J. Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin. Ann N Y Acad Sci 2016;1380:183-94. [PMID: 27441783 DOI: 10.1111/nyas.13157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 O'Sullivan KE, Phelan JJ, O'Hanlon C, Lysaght J, O'Sullivan JN, Reynolds JV. The role of inflammation in cancer of the esophagus. Expert Rev Gastroenterol Hepatol. 2014;8:749-760. [PMID: 24857183 DOI: 10.1586/17474124.2014.913478] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
9 Sharma T, Gupta A, Chauhan R, Bhat AA, Nisar S, Hashem S, Akhtar S, Ahmad A, Haris M, Singh M, Uddin S. Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis. Cancer Metastasis Rev 2022. [PMID: 35511379 DOI: 10.1007/s10555-022-10026-6] [Reference Citation Analysis]
10 Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, Farthing MJ. Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut. 2002;51:316-322. [PMID: 12171950 DOI: 10.1136/gut.51.3.316] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 6.3] [Reference Citation Analysis]
11 O’Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in theesophagus. Am J Gastroenterol. 2005;100:1257-1264. [PMID: 15929754 DOI: 10.1111/j.1572-0241.2005.41338.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 147] [Article Influence: 8.9] [Reference Citation Analysis]
12 Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G, Ray M, Katz JA, Catanzaro A, O’shea R, Post AB, Wong R, Sivak MV, Mccormick T, Phillips M, West GA, Willis JE, Biancani P, Fiocchi C. Gastroesophageal Reflux Disease–Associated Esophagitis Induces Endogenous Cytokine Production Leading to Motor Abnormalities. Gastroenterology 2007;132:154-65. [DOI: 10.1053/j.gastro.2006.10.009] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 6.3] [Reference Citation Analysis]
13 Trowbridge R, Mittal SK, Agrawal DK. Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomarkers Prev 2013;22:1007-14. [PMID: 23563888 DOI: 10.1158/1055-9965.EPI-13-0085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
14 Nicholson A, Jankowski J. Acid Reflux and Oesophageal Cancer. In: Jankowski JAZ, editor. Inflammation and Gastrointestinal Cancers. Berlin: Springer Berlin Heidelberg; 2011. pp. 65-82. [DOI: 10.1007/978-3-642-03503-6_4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
15 Kanazawa Y, Isomoto H, Wen CY, Wang AP, Saenko VA, Ohtsuru A, Takeshima F, Omagari K, Mizuta Y, Murata I, Yamashita S, Kohno S. Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease. World J Gastroenterol 2003; 9(12): 2801-2804 [PMID: 14669337 DOI: 10.3748/wjg.v9.i12.2801] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
16 Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res. 2012;18:2138-2144. [PMID: 22344232 DOI: 10.1158/1078-0432.ccr-11-0934] [Cited by in Crossref: 93] [Cited by in F6Publishing: 63] [Article Influence: 9.3] [Reference Citation Analysis]
17 Menke V, van Zoest KP, Moons LM, Hansen B, Pot RG, Siersema PD, Kusters JG, Kuipers EJ. Nco I TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma. Scandinavian Journal of Gastroenterology 2012;47:378-86. [DOI: 10.3109/00365521.2011.650192] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
18 Lin YH, Chang TS, Yao YC, Li YC. Increased Risk of Chronic Sinusitis in Adults With Gastroesophgeal Reflux Disease: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 2015;94:e1642. [PMID: 26426655 DOI: 10.1097/MD.0000000000001642] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
19 Hong SJ, Park SH, Moon JS, Shin WG, Kim JG, Lee YC, Lee DH, Jang JY, Kim JJ, Lee HL, Lee SW, Hwangbo Y, Xu J, Wang B, Xue Z, Liu F, Yuan Y, Leelakusolvong S, Dy F. The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. Gut Liver 2016;10:910-6. [PMID: 27282265 DOI: 10.5009/gnl15537] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lucendo AJ. Esophageal manifestations of celiac disease: Celiac disease esophageal manifestations. Diseases of the Esophagus 2011;24:470-5. [DOI: 10.1111/j.1442-2050.2011.01190.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Kandulski A, Malfertheiner P. Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9:15-22. [PMID: 22105108 DOI: 10.1038/nrgastro.2011.210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
22 Lao-sirieix P, Fitzgerald R. Role of the micro-environment in Barrett's carcinogenesis. Biochemical Society Transactions 2010;38:327-30. [DOI: 10.1042/bst0380327] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
23 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls. J Neurogastroenterol Motil 2016;22:630-42. [PMID: 27557545 DOI: 10.5056/jnm16019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Lind A, Siersema PD, Kusters JG, Konijn T, Mebius RE, Koenderman L. The Microenvironment in Barrett's Esophagus Tissue Is Characterized by High FOXP3 and RALDH2 Levels. Front Immunol 2018;9:1375. [PMID: 29967615 DOI: 10.3389/fimmu.2018.01375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology. 2010;138:854-869. [PMID: 20080098 DOI: 10.1053/j.gastro.2010.01.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
26 Baghdadi J, Chaudhary N, Pei Z, Yang L. Microbiome, innate immunity, and esophageal adenocarcinoma. Clinics in laboratory medicine. 2014;34:721-732. [PMID: 25439272 DOI: 10.1016/j.cll.2014.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
27 Ali I, Rafiee P, Zheng Y, Johnson C, Banerjee B, Haasler G, Jacob H, Shaker R. Intramucosal distribution of WNT signaling components in human esophagus. J Clin Gastroenterol 2009;43:327-37. [PMID: 19309775 DOI: 10.1097/mcg.0b013e31816256ff] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
28 Forte JG. The gastric parietal cell: at home and abroad. Eur Surg 2010;42:134-48. [DOI: 10.1007/s10353-010-0539-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A. Shape of Barrett’s epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol 2010; 16(4): 484-489 [PMID: 20101776 DOI: 10.3748/wjg.v16.i4.484] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
30 Isomoto H, Nishi Y, Wang A, Takeshima F, Omagari K, Mizuta Y, Shikuwa S, Murata I, Kohno S. Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 2004;99:1063-8. [PMID: 15180726 DOI: 10.1111/j.1572-0241.2004.30847.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
31 Matthews PJ, Knowles CH, Chua YC, Delaney C, Hobson AR, Aziz Q. Effects of the concentration and frequency of acid infusion on the development and maintenance of esophageal hyperalgesia in a human volunteer model. Am J Physiol Gastrointest Liver Physiol 2008;294:G914-7. [PMID: 18258794 DOI: 10.1152/ajpgi.00445.2007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
32 Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A. Inflammation and Barrett's carcinogenesis. Pathol Res Pract. 2012;208:269-280. [PMID: 22541897 DOI: 10.1016/j.prp.2012.03.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
33 Rajendra S. Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm? Best Pract Res Clin Gastroenterol 2015;29:65-75. [PMID: 25743457 DOI: 10.1016/j.bpg.2014.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
34 Mulder DJ, Pooni A, Mak N, Hurlbut DJ, Basta S, Justinich CJ. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am J Pathol 2011;178:744-53. [PMID: 21281807 DOI: 10.1016/j.ajpath.2010.10.027] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
35 Kavanagh ME, Conroy MJ, Clarke NE, Gilmartin NT, O'sullivan KE, Feighery R, Maccarthy F, O'toole D, Ravi N, Reynolds JV, O'sullivan J, Lysaght J. Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma. Cancer Letters 2016;370:117-24. [DOI: 10.1016/j.canlet.2015.10.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
36 de Vries DR, Ter Linde JJ, van Herwaarden MA, Schwartz MP, Shephard P, Geng MM, Smout AJ, Samsom M. In GERD patients, mucosal repair associated genes are upregulated in non-inflamed oesophageal epithelium. J Cell Mol Med 2009;13:936-47. [PMID: 19413890 DOI: 10.1111/j.1582-4934.2008.00626.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Abdel-Latif MM, Kelleher D, Reynolds JV. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target. J Surg Res 2009;153:172-80. [PMID: 18533190 DOI: 10.1016/j.jss.2007.12.755] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
38 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls. Neurogastroenterol Motil 2017;29:e12992. [DOI: 10.1111/nmo.12992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lin K, Chen X, Zhang L, Wang Y, Shan Z. Proton pump inhibitors as also inhibitors of atrial fibrillation. Eur J Pharmacol 2013;718:435-40. [PMID: 23973848 DOI: 10.1016/j.ejphar.2013.07.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
40 Fujiwara Y, Higuchi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Functional oesophageal epithelial defense against acid. Inflammopharmacol 2005;13:1-13. [DOI: 10.1163/156856005774423953] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
41 Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol. 2009;9:396-404. [PMID: 19596608 DOI: 10.1016/j.coph.2009.06.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
42 Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, Zhang X, Yu C, Hormi-Carver K, Genta RM, Spechler SJ. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776-1784. [PMID: 19660463 DOI: 10.1053/j.gastro.2009.07.055] [Cited by in Crossref: 226] [Cited by in F6Publishing: 203] [Article Influence: 17.4] [Reference Citation Analysis]
43 Lao-sirieix P, Corovic A, Jankowski J, Lowe A, Triadafilopoulos G, Fitzgerald RC. Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus: pHi regulation in barrett's esophagus. Diseases of the Esophagus 2008;21:529-38. [DOI: 10.1111/j.1442-2050.2007.00807.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
44 Kim HS, Conklin JL, Park H. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux. Aliment Pharmacol Ther 2006;24:1029-36. [DOI: 10.1111/j.1365-2036.2006.03091.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
45 Baruah A, Buttar NS. Chemoprevention in Barrett's oesophagus. Best Pract Res Clin Gastroenterol 2015;29:151-65. [PMID: 25743463 DOI: 10.1016/j.bpg.2014.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Chandra S, Gorospe EC, Leggett CL, Wang KK. Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance. Curr Gastroenterol Rep 2013;15:322. [PMID: 23605564 DOI: 10.1007/s11894-013-0322-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
47 Rafiee P, Ogawa H, Heidemann J, Li MS, Aslam M, Lamirand TH, Fisher PJ, Graewin SJ, Dwinell MB, Johnson CP, Shaker R, Binion DG. Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation. Am J Physiol Gastrointest Liver Physiol 2003;285:G1277-92. [PMID: 12919942 DOI: 10.1152/ajpgi.00484.2002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
48 Kumar S, Singh M, Rawat JK, Gautam S, Saraf SA, Kaithwas G. Effect of rutin against gastric esophageal reflux in experimental animals. Toxicol Mech Methods 2014;24:666-71. [PMID: 25191975 DOI: 10.3109/15376516.2014.961215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
49 Lind A, Koenderman L, Kusters JG, Siersema PD. Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype. PLoS One 2014;9:e106261. [PMID: 25170842 DOI: 10.1371/journal.pone.0106261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Colleypriest BJ, Palmer RM, Ward SG, Tosh D. Cdx genes, inflammation and the pathogenesis of Barrett's metaplasia. Trends Mol Med. 2009;15:313-322. [PMID: 19564133 DOI: 10.1016/j.molmed.2009.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
51 Shan J, Oshima T, Farre R, Fukui H, Watari J, Miwa H. IL-4 induces columnar-like differentiation of esophageal squamous epithelium through JAK/PI3K pathway: possible role in pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2014;306:G641-9. [PMID: 24578343 DOI: 10.1152/ajpgi.00386.2013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
52 Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Bamias G, Michopoulos S, Savva S, Tzias V, Zouboulis-vafiadis I, Kamberoglou D, Ladas SD. Inflammatory infiltration of metaplastic epithelium and correlation to previous diagnosis of esophagitis and Barrett's length. Scandinavian Journal of Gastroenterology 2012;47:900-6. [DOI: 10.3109/00365521.2012.688214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Brock C, Gregersen H, Gyawali CP, Lottrup C, Furnari M, Savarino E, Novais L, Frøkjaer JB, Bor S, Drewes AM. The sensory system of the esophagus--what do we know?: The sensory system of the esophagus. Ann N Y Acad Sci 2016;1380:91-103. [DOI: 10.1111/nyas.13205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Lam S, Hart AR. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis. Diseases of the Esophagus 2017;30:1-10. [DOI: 10.1093/dote/dox099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
56 Delvenne P, Hubert P, Jacobs N. Epithelial metaplasia: an inadequate environment for antitumour immunity? Trends in Immunology 2004;25:169-73. [DOI: 10.1016/j.it.2004.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
57 De Jonge PJ, Siersema PD, Van Breda SG, Van Zoest KP, Bac DJ, Leeuwenburgh I, Ouwendijk RJ, Van Dekken H, Kusters JG, Kuipers EJ. Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts. Aliment Pharmacol Ther. 2008;28:127-136. [PMID: 18384663 DOI: 10.1111/j.1365-2036.2008.03699.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
58 Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase K, Hayashi T, Inoue K. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol. 2003;98:551-556. [PMID: 12650786 DOI: 10.1111/j.1572-0241.2003.07303.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
59 Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D. New Molecular Concepts of Barrett’s Esophagus: Clinical Implications and Biomarkers. Journal of Surgical Research 2005;125:189-212. [DOI: 10.1016/j.jss.2004.12.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
60 Lind A, Siersema PD, Kusters JG, Van der Linden JA, Knol EF, Koenderman L. The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue. PLoS One. 2012;7:e33899. [PMID: 22509265 DOI: 10.1371/journal.pone.0033899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
61 Mauchley D, Meng X, Babu A, Gamboni-Robertson F, Yang X, Banerjee A, Fullerton DA, Weyant MJ. Gastroduodenal reflux induces group IIa secretory phospholipase A(2) expression and activity in murine esophagus. Dis Esophagus 2010;23:430-6. [PMID: 20095996 DOI: 10.1111/j.1442-2050.2009.01034.x] [Reference Citation Analysis]
62 Cantù P, Savojardo D, Carmagnola S, Penagini R. Impact of referral for gastro-oesophageal reflux disease on the workload of an academic Gastroenterology Unit. Dig Liver Dis. 2005;37:735-740. [PMID: 16024304 DOI: 10.1016/j.dld.2005.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
63 Harnett KM, Rieder F, Behar J, Biancani P. Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa. J Neurogastroenterol Motil 2010;16:374-88. [PMID: 21103419 DOI: 10.5056/jnm.2010.16.4.374] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
64 Verbeke H, Geboes K, Van Damme J, Struyf S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta. 2012;1825:117-129. [PMID: 22079531 DOI: 10.1016/j.bbcan.2011.10.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 68] [Article Influence: 2.0] [Reference Citation Analysis]
65 Wu P, Zhou L, Li YJ, Luo B, Yi LS, Chen SF, Sun HH, Chen Y, Cao ZJ, Xu SC. Protective effects of quercetin against chronic mixed reflux esophagitis in rats by inhibiting the nuclear factor-κB p65 and interleukin-8 signaling pathways: Quercetin and reflux esophagitis. Journal of Digestive Diseases 2015;16:319-26. [DOI: 10.1111/1751-2980.12249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
66 Zhang J, Xie PY, Li H, Shuai XW, Wang C. Protective effects of cholinergic anti-inflammatory pathway against acute esophagitis in rats. Shijie Huaren Xiaohua Zazhi 2008; 16(20): 2204-2210 [DOI: 10.11569/wcjd.v16.i20.2204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Huo X, Souza RF. Acid burn or cytokine sizzle in the pathogenesis of heartburn? J Gastroenterol Hepatol. 2013;28:385-387. [PMID: 23441717 DOI: 10.1111/jgh.12103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
68 Binato M, Fagundes R, Gurski R, Meurer L, Edelweiss MI. Immunohistochemical overexpression of the p53 protein and Ki-67 (MIB-1) antigen in patients with GERD and chronic esophagitis. Appl Immunohistochem Mol Morphol 2010;18:236-43. [PMID: 20414055 DOI: 10.1097/PAI.0b013e3181c49134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Isomoto H, Nishi Y, Kanazawa Y, Shikuwa S, Mizuta Y, Inoue K, Kohno S. Immune and Inflammatory Responses in GERD and Lansoprazole. J Clin Biochem Nutr 2007;41:84-91. [PMID: 18193101 DOI: 10.3164/jcbn.2007012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
70 Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010;16:5824-34. [PMID: 20947516 DOI: 10.1158/1078-0432.CCR-10-1110] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
71 Rajendra S, Ackroyd R, Karim N, Mohan C, Ho JJ, Kutty MK. Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus. J Clin Pathol 2006;59:952-7. [PMID: 16467164 DOI: 10.1136/jcp.2005.031575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
72 Zavala-Solares MR, Fonseca-Camarillo G, Valdovinos M, Granados J, Grajales-Figueroa G, Zamora-Nava L, Aguilar-Olivos N, Valdovinos-García LR, Yamamoto-Furusho JK. Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study. BMC Gastroenterol 2021;21:201. [PMID: 33941087 DOI: 10.1186/s12876-021-01707-7] [Reference Citation Analysis]
73 Moons LM, Kusters JG, van Delft JH, Kuipers EJ, Gottschalk R, Geldof H, Bode WA, Stoof J, van Vliet AH, Ketelslegers HB, Kleinjans JC, Siersema PD. A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis 2008;29:926-31. [PMID: 18192685 DOI: 10.1093/carcin/bgm241] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
74 Dunbar KB, Agoston AT, Odze RD, Huo X, Pham TH, Cipher DJ, Castell DO, Genta RM, Souza RF, Spechler SJ. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA 2016;315:2104-12. [PMID: 27187303 DOI: 10.1001/jama.2016.5657] [Cited by in Crossref: 109] [Cited by in F6Publishing: 77] [Article Influence: 18.2] [Reference Citation Analysis]
75 Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323-2333. [PMID: 24562599 DOI: 10.1007/s00464-014-3461-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
76 Souza RF. Bringing GERD Management up to PAR-2. Am J Gastroenterol 2010;105:1944-6. [PMID: 20818348 DOI: 10.1038/ajg.2010.272] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
77 Lahiri S, Singh P, Singh S, Rasheed N, Palit G, Pant KK. Melatonin protects against experimental reflux esophagitis. J Pineal Res. 2009;46:207-213. [PMID: 19067786 DOI: 10.1111/j.1600-079x.2008.00650.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
78 Ma J, Altomare A, Guarino M, Cicala M, Rieder F, Fiocchi C, Li D, Cao W, Behar J, Biancani P. HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2012;303:G635-G645. [PMID: 22790593 DOI: 10.1152/ajpgi.00097.2012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
79 Parsel SM, Wu EL, Riley CA, McCoul ED. Gastroesophageal and Laryngopharyngeal Reflux Associated With Laryngeal Malignancy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2019;17:1253-1264.e5. [PMID: 30366155 DOI: 10.1016/j.cgh.2018.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
80 Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. The homeodomain protein CDX2 is an early marker of Barrett’s oesophagus. J Clin Pathol. 2004;57:1063-1068. [PMID: 15452161 DOI: 10.1136/jcp.2003.015727] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
81 Zhong YQ, Lin Y, Xu Z. Expression of IFN-γ and IL-4 in the esophageal mucosa of patients with reflux esophagitis and Barrett's esophagus and their relationship with endoscopic and histologic grading. Dig Dis Sci 2011;56:2865-70. [PMID: 21479676 DOI: 10.1007/s10620-011-1696-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
82 Power R, Lowery MA, Reynolds JV, Dunne MR. The Cancer-Immune Set Point in Oesophageal Cancer. Front Oncol. 2020;10:891. [PMID: 32582553 DOI: 10.3389/fonc.2020.00891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
83 Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM, Kleinjan A, Kwekkeboom J, van Vliet AH, Siersema PD. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005;207:269-76. [PMID: 16177953 DOI: 10.1002/path.1847] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.2] [Reference Citation Analysis]
84 Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1131-G1139. [PMID: 15271650 DOI: 10.1152/ajpgi.00216.2004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
85 Nam HH, Nan L, Choo BK. Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities. Int J Mol Sci 2018;19:E3622. [PMID: 30453554 DOI: 10.3390/ijms19113622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 Shutt JD, Boger P, Neale JR, Patel P, Sampson AP. Activity of the leukotriene pathway in Barrett's metaplasia and oesophageal adenocarcinoma. Inflamm Res 2012;61:1379-84. [PMID: 22851204 DOI: 10.1007/s00011-012-0539-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr. 2007;40:13-23. [PMID: 18437209 DOI: 10.3164/jcbn.40.13] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
88 Cuomo A, Romano M, Rocco A, Budillon G, Del Vecchio Blanco C, Nardone G. Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut. 2003;52:514-517. [DOI: 10.1136/gut.52.4.514] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
89 Barbera M, Fitzgerald RC. Cellular Mechanisms of Barrett's Esophagus Development. Surgical Oncology Clinics of North America 2009;18:393-410. [DOI: 10.1016/j.soc.2009.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
90 Peitz U, Kouznetsova I, Wex T, Gebert I, Vieth M, Roessner A, Hoffmann W, Malfertheiner P. TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD). Peptides. 2004;25:771-777. [PMID: 15177871 DOI: 10.1016/j.peptides.2004.01.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
91 Yoshida N, Imamoto E, Uchiyama K, Kuroda M, Naito Y, Mukaida N, Kawabe A, Shimada Y, Yoshikawa T, Okanoue T. Molecular mechanisms involved in interleukin-8 production by normal human oesophageal epithelial cells: BILE ACID-INDUCED IL-8 PRODUCTION IN OESOPHAGEAL EPITHELIAL CELLS. Alimentary Pharmacology & Therapeutics 2006;24:219-26. [DOI: 10.1111/j.1365-2036.2006.00049.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
92 Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007;102:1301-6. [PMID: 17531015 DOI: 10.1111/j.1572-0241.2007.01179.x] [Cited by in Crossref: 245] [Cited by in F6Publishing: 207] [Article Influence: 16.3] [Reference Citation Analysis]
93 Quante M, Graham TA, Jansen M. Insights Into the Pathophysiology of Esophageal Adenocarcinoma. Gastroenterology. 2018;154:406-420. [PMID: 29037468 DOI: 10.1053/j.gastro.2017.09.046] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
94 Steiner SJ, Kernek KM, Fitzgerald JF. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006;42:506-9. [PMID: 16707971 DOI: 10.1097/01.mpg.0000221906.06899.1b] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
95 Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 2016; 22(5): 1800-1810 [PMID: 26855539 DOI: 10.3748/wjg.v22.i5.1800] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
96 Berndt U, Philipsen L, Bartsch S, Hu Y, Röcken C, Bertram W, Hämmerle M, Rösch T, Sturm A. Comparative Multi-Epitope-Ligand-Cartography reveals essential immunological alterations in Barrett's metaplasia and esophageal adenocarcinoma. Mol Cancer 2010;9:177. [PMID: 20604962 DOI: 10.1186/1476-4598-9-177] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
97 Lee TS, Song HJ, Jeong JH, Min YS, Shin CY, Sohn UD. IL-1β activates p44/42 and p38 mitogen-activated protein kinases via different pathways in cat esophageal smooth muscle cells. World J Gastroenterol 2006; 12(5): 716-722 [PMID: 16521184 DOI: 10.3748/wjg.v12.i5.716] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
98 Kaymak T, Hruz P, Niess JH. Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases. FEBS J 2021. [PMID: 34213831 DOI: 10.1111/febs.16103] [Reference Citation Analysis]
99 Davelaar AL, Straub D, Buttar NS, Fockens P, Krishnadath KK. Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence. Scand J Gastroenterol. 2015;50:321-332. [PMID: 25562781 DOI: 10.3109/00365521.2014.940379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
100 Fass R. Gastroesophageal reflux disease revisited. Gastroenterol Clin North Am. 2002;31:S1-S10. [PMID: 12489466 DOI: 10.1016/s0889-8553(02)00046-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
101 Fox M, Forgacs I. Gastro-oesophageal reflux disease. BMJ. 2006;332:88-93. [PMID: 16410582 DOI: 10.1136/bmj.332.7533.88] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
102 Kavanagh ME, O'Sullivan KE, O'Hanlon C, O'Sullivan JN, Lysaght J, Reynolds JV. The esophagitis to adenocarcinoma sequence; the role of inflammation. Cancer Lett. 2013; Aug 27. [Epub ahead of print]. [PMID: 23994342 DOI: 10.1016/j.canlet.2013.08.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
103 Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer. 2003;3:676-684. [PMID: 12951586 DOI: 10.1038/nrc1166] [Cited by in Crossref: 189] [Cited by in F6Publishing: 173] [Article Influence: 9.9] [Reference Citation Analysis]
104 Gough MD, Ackroyd R, Majeed AW, Bird NC. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important? Am J Gastroenterol 2005;100:1012-8. [PMID: 15842572 DOI: 10.1111/j.1572-0241.2005.40904.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
105 Altomare A, Ma J, Guarino MP, Cheng L, Rieder F, Ribolsi M, Fiocchi C, Biancani P, Harnett K, Cicala M. Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil 2012;24:943-e463. [PMID: 22734465 DOI: 10.1111/j.1365-2982.2012.01963.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Asonuma S, Imatani A, Asano N, Oikawa T, Konishi H, Iijima K, Koike T, Ohara S, Shimosegawa T. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression. Am J Physiol Gastrointest Liver Physiol. 2009;297:G312-G322. [PMID: 19520737 DOI: 10.1152/ajpgi.00518.2007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
107 Zhang HY, Zhang Q, Zhang X, Yu C, Huo X, Cheng E, Wang DH, Spechler SJ, Souza RF. Cancer-related inflammation and Barrett’s carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett’s cells. Am J Physiol Gastrointest Liver Physiol. 2011;300:G454-G460. [PMID: 21148399 DOI: 10.1152/ajpgi.00458.2010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
108 Gao S, Brown J, Wang H, Feng X. The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer. Arch Immunol Ther Exp (Warsz) 2014;62:131-44. [PMID: 24276788 DOI: 10.1007/s00005-013-0263-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
109 Zeb MH, Baruah A, Kossak SK, Buttar NS. Chemoprevention in Barrett's Esophagus: Current Status. Gastroenterol Clin North Am 2015;44:391-413. [PMID: 26021201 DOI: 10.1016/j.gtc.2015.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Falk GW, Jacobson BC, Riddell RH, Rubenstein JH, El-Zimaity H, Drewes AM, Roark KS, Sontag SJ, Schnell TG, Leya J. Barrett’s esophagus: prevalence-incidence and etiology-origins. Ann N Y Acad Sci. 2011;1232:1-17. [PMID: 21950804 DOI: 10.1111/j.1749-6632.2011.06042.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
111 Takashima S, Tanaka F, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Yamagami H, Tanigawa T, Fukumoto S, Watanabe T, Fujiwara Y. Barrett’s esophagus is negatively associated with eosinophilic esophagitis in Japanese subjects. Esophagus 2019;16:168-73. [DOI: 10.1007/s10388-018-0648-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Huo X, Zhang X, Yu C, Zhang Q, Cheng E, Wang DH, Pham TH, Spechler SJ, Souza RF. In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1. Gut 2014;63:1042-52. [PMID: 24048734 DOI: 10.1136/gutjnl-2013-305533] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
113 Galmiche JP, Zerbib F, des Varannes SB. Treatment of GORD: Three decades of progress and disappointments. United European Gastroenterol J 2013;1:140-50. [PMID: 24917952 DOI: 10.1177/2050640613484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
114 Sen M, Hahn F, Black TA, DeMarshall M, Porter W, Snowden E, Yee SS, Tong F, Ferguson M, Fleshman EN, Nakagawa H, Falk GW, Ginsberg GG, Kochman ML, Blaesius R, Rustgi AK, Carpenter EL. Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue. Oncotarget 2019;10:3592-604. [PMID: 31217895 DOI: 10.18632/oncotarget.26911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Saadi A, Shannon NB, Lao-Sirieix P, O’Donovan M, Walker E, Clemons NJ, Hardwick JS, Zhang C, Das M, Save V. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci USA. 2010;107:2177-2182. [PMID: 20080664 DOI: 10.1073/pnas.0909797107] [Cited by in Crossref: 110] [Cited by in F6Publishing: 133] [Article Influence: 9.2] [Reference Citation Analysis]
116 Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett. 2009;275:170-177. [PMID: 18703277 DOI: 10.1016/j.canlet.2008.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
117 Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Wei M, Wanibuchi H, Arakawa T. Role of Th-2 cytokines in the development of Barrett's esophagus in rats. J Gastroenterol 2011;46:883-93. [PMID: 21590343 DOI: 10.1007/s00535-011-0405-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
118 Maev IV, Lyamina SV, Мalysheva EV, Yurenev GL, Malyshev IY. [An immune response and an alveolar macrophage phenotype in asthma, gastroesophageal reflux disease and their concurrence]. Ter Arkh 2015;87:34-41. [PMID: 26027238 DOI: 10.17116/terarkh201587334-41] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
119 Kapoor H, Agrawal DK, Mittal SK. Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny. Transl Res 2015;166:28-40. [PMID: 25701368 DOI: 10.1016/j.trsl.2015.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
120 Herfs M, Hubert P, Delvenne P. Epithelial metaplasia: Adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol Med. 2009;15:245-253. [PMID: 19457719 DOI: 10.1016/j.molmed.2009.04.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
121 Jego M, Volant A, Faycal J, Doucet L, Andlauer E, Delalande AH, Cholet F, Nousbaum JB, Gouérou H, Robaszkiewicz M. Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol 2007;31:601-6. [PMID: 17646787 DOI: 10.1016/s0399-8320(07)89437-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
122 Altomare A, Ma J, Guarino MP, Cheng L, Rieder F, Ribolsi M, Fiocchi C, Biancani P, Harnett K, Cicala M. Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil 2012;24:943-e463. [PMID: 22734465 DOI: 10.1111/j.1365-2982.2012.01963.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
123 Isomoto H, Saenko VA, Kanazawa Y, Nishi Y, Ohtsuru A, Inoue K, Akazawa Y, Takeshima F, Omagari K, Miyazaki M, Mizuta Y, Murata I, Yamashita S, Kohno S. Enhanced Expression of Interleukin-8 and Activation of Nuclear Factor Kappa-B in Endoscopy-negative Gastroesophageal Reflux Disease. Am J Gastroenterol 2004;99:589-97. [DOI: 10.1111/j.1572-0241.2004.04110.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 3.4] [Reference Citation Analysis]
124 Han G, Leem J, Lee H, Lee J. Electroacupuncture to treat gastroesophageal reflux disease: study protocol for a randomized controlled trial. Trials 2016;17:246. [PMID: 27188910 DOI: 10.1186/s13063-016-1371-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
125 Lagisetty KH, McEwen DP, Nancarrow DJ, Schiebel JG, Ferrer-Torres D, Ray D, Frankel TL, Lin J, Chang AC, Kresty LA, Beer DG. Immune determinants of Barrett's progression to esophageal adenocarcinoma. JCI Insight 2021;6:143888. [PMID: 33290281 DOI: 10.1172/jci.insight.143888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
126 Kim JJ, Kim N, Choi YJ, Kim JS, Jung HC. Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms. Medicine (Baltimore) 2016;95:e4387. [PMID: 27512850 DOI: 10.1097/MD.0000000000004387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
127 Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg 2009;141:559-63. [PMID: 19861190 DOI: 10.1016/j.otohns.2009.08.022] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
128 Ahmed Osman H, Aly SS, Mahmoud HS, Ahmed EH, Salah Eldin EM, Abdelrahim EA, El Masry MA, Herdan RA, Hassan MH. Effect of Acid Suppression on Peripheral T-Lymphocyte Subsets and Immunohistochemical Esophageal Mucosal Changes in Patients With Gastroesophageal Reflux Disease. J Clin Gastroenterol 2019;53:e362-70. [PMID: 30119091 DOI: 10.1097/MCG.0000000000001098] [Reference Citation Analysis]
129 Giri AK, Rawat JK, Singh M, Gautam S, Kaithwas G. Effect of lycopene against gastroesophageal reflux disease in experimental animals. BMC Complement Altern Med 2015;15:110. [PMID: 25888837 DOI: 10.1186/s12906-015-0631-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
130 Kelly EA, Samuels TL, Johnston N. Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line. Otolaryngol Head Neck Surg 2014;150:618-24. [PMID: 24376122 DOI: 10.1177/0194599813517862] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
131 Kohata Y, Nakahara K, Tanigawa T, Yamagami H, Shiba M, Watanabe T, Tominaga K, Fujiwara Y, Arakawa T. Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model. Dig Dis Sci 2015;60:2654-61. [PMID: 25862640 DOI: 10.1007/s10620-015-3662-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
132 Wong NA, Wilding J, Bartlett S, Liu Y, Warren BF, Piris J, Maynard N, Marshall R, Bodmer WF. CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci USA. 2005;102:7565-7570. [PMID: 15894614 DOI: 10.1073/pnas.0502031102] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
133 Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med (Maywood) 2014;239:1108-23. [PMID: 24781339 DOI: 10.1177/1535370214529388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
134 Katada K, Yoshida N, Isozaki Y, Tomatsuri N, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Prevention by rebamipide of acute reflux esophagitis in rats. Dig Dis Sci. 2005;50 Suppl 1:S97-S103. [PMID: 16184428 DOI: 10.1007/s10620-005-2813-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
135 Shan J, Oshima T, Wu L, Fukui H, Watari J, Miwa H. Interferon γ-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines. PLoS One 2016;11:e0151701. [PMID: 26986625 DOI: 10.1371/journal.pone.0151701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
136 Bellizzi AM, Nardone G, Compare D, Bor S, Capanoglu D, Farré R, Neumann H, Neurath MF, Vieth M, Chen H, Chen X. Tissue resistance in the normal and diseased esophagus: Esophageal tissue resistance. Ann N Y Acad Sci 2013;1300:200-12. [DOI: 10.1111/nyas.12248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Isomoto H, Kanazawa Y, Nishi Y, Wen CY, Inoue K, Kohno S. Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis. World J Gastroenterol 2005; 11(12): 1793-1797 [PMID: 15793866 DOI: 10.3748/wjg.v11.i12.1793] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
138 Dvorak K, Dvorak B. Role of interleukin-6 in Barrett’s esophagus pathogenesis. World J Gastroenterol 2013; 19(15): 2307-2312 [PMID: 23613623 DOI: 10.3748/wjg.v19.i15.2307] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
139 Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G571-G581. [PMID: 20299604 DOI: 10.1152/ajpgi.00454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Ma J, Altomare A, de la Monte S, Tong M, Rieder F, Fiocchi C, Behar J, Shindou H, Biancani P, Harnett KM. HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am J Physiol Gastrointest Liver Physiol. 2010;299:G791-G798. [PMID: 20616304 DOI: 10.1152/ajpgi.00160.2010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
141 Bax DA, Siersema PD, Van Vliet AH, Kuipers EJ, Kusters JG. Molecular alterations during development of esophageal adenocarcinoma. J Surg Oncol 2005;92:89-98. [DOI: 10.1002/jso.20353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
142 Miftahussurur M, Doohan D, Nusi IA, Adi P, Rezkitha YAA, Waskito LA, Fauzia KA, Bramantoro T, Maimunah U, Thamrin H, Masithah SI, Sukadiono S, Uchida T, Lusida MI, Yamaoka Y. Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence. PLoS One 2018;13:e0205644. [PMID: 30427843 DOI: 10.1371/journal.pone.0205644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
143 Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Reference Citation Analysis]
144 Trowbridge R, Kizer RT, Mittal SK, Agrawal DK. 1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Expert Rev Clin Immunol. 2013;9:517-533. [PMID: 23730883 DOI: 10.1586/eci.13.38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
145 Maitra I, Date RS, Martin FL. Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.Clin J Gastroenterol. 2020;13:635-649. [PMID: 32495144 DOI: 10.1007/s12328-020-01135-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
146 Green NH, Huang Q, Corfe BM, Bury JP, MacNeil S. NF-κB is activated in oesophageal fibroblasts in response to a paracrine signal generated by acid-exposed primary oesophageal squamous cells. Int J Exp Pathol 2011;92:345-56. [PMID: 21668534 DOI: 10.1111/j.1365-2613.2011.00778.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
147 Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131-137. [PMID: 17245209 DOI: 10.1097/01.mcg.0000225631.07039.6d] [Cited by in Crossref: 169] [Cited by in F6Publishing: 152] [Article Influence: 11.3] [Reference Citation Analysis]
148 Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Michopoulos S, Savva S, Tzias V, Zouboulis-Vafiadis I, Kamberoglou D. Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter? Dig Dis Sci. 2012;57:1190-1196. [PMID: 22147251 DOI: 10.1007/s10620-011-1990-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
149 Nguyen NQ, Holloway RH. Gastroesophageal reflux disease. Curr Opin Gastroenterol. 2003;19:373-378. [PMID: 15703580 DOI: 10.1097/00001574-200307000-00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
150 Chen J, Hou N, Zhang C, Teng Y, Cheng X, Li Z, Ren J, Zeng J, Li R, Wang W, Yang X, Lan Y. Smooth Muscle Hgs Deficiency Leads to Impaired Esophageal Motility. Int J Biol Sci 2015;11:794-802. [PMID: 26078721 DOI: 10.7150/ijbs.12248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
151 Mehta S, Johnson IT, Rhodes M. Systematic review: the chemoprevention of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2005;22:759-68. [DOI: 10.1111/j.1365-2036.2005.02667.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
152 Fitzgerald RC, Farthing MJ. The pathogenesis of Barrett's esophagus. Gastrointest Endosc Clin N Am 2003;13:233-55. [PMID: 12916657 DOI: 10.1016/s1052-5157(03)00007-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
153 Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G571-G581. [PMID: 20299604 DOI: 10.1152/ajpgi.00454.2009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
154 Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, Blumin JH, Bock JM. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells. Laryngoscope 2012;122:1317-25. [PMID: 22570308 DOI: 10.1002/lary.23307] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 6.9] [Reference Citation Analysis]
155 Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther. 2006;23:321-329. [PMID: 16393313 DOI: 10.1111/j.1365-2036.2006.02747.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
156 Chemnitzer O, Götzel K, Maurer L, Dietrich A, Eichfeld U, Lyros O, Jansen-Winkeln B, Hoffmeister A, Gockel I, Thieme R. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus. Dig Dis Sci 2017;62:3391-401. [PMID: 29086334 DOI: 10.1007/s10620-017-4821-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
157 Shan J, Oshima T, Muto T, Yasuda K, Fukui H, Watari J, Nakanishi K, Miwa H. Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis. J Gastroenterol 2015;50:414-23. [DOI: 10.1007/s00535-014-0988-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
158 Abdalla SI, Sanderson IR, Fitzgerald RC. Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. Carcinogenesis. 2005;26:1627-1633. [PMID: 15878911 DOI: 10.1093/carcin/bgi114] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
159 Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Ann N Y Acad Sci 2021;1486:3-14. [PMID: 33015827 DOI: 10.1111/nyas.14501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Fitzgerald RC. Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810-1820. [PMID: 17124160 DOI: 10.1136/gut.2005.089144] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
161 Tutar E, Ertem D, Unluguzel G, Tanrikulu S, Haklar G, Celikel C, Ademoglu E, Pehlivanoglu E. Reactive oxygen species and chemokines: Are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease? World J Gastroenterol 2008; 14(20): 3218-3223 [PMID: 18506929 DOI: 10.3748/wjg.14.3218] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
162 Wright BL, Nguyen N, Shim KP, Masterson JC, Jacobsen EA, Ochkur SI, Lee JJ, Furuta GT. Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease. J Allergy Clin Immunol 2018;141:1919-1921.e5. [PMID: 29374572 DOI: 10.1016/j.jaci.2017.12.993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
163 Peters CJ, Fitzgerald RC. Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma: SYSTEMATIC REVIEW: OESOPHAGEAL ADENOCARCINOMA. Alimentary Pharmacology & Therapeutics 2007;25:1253-69. [DOI: 10.1111/j.1365-2036.2007.03325.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
164 Ma J, Altomare A, Guarino M, Cicala M, Rieder F, Fiocchi C, Li D, Cao W, Behar J, Biancani P, Harnett KM. HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2012;303:G635-45. [PMID: 22790593 DOI: 10.1152/ajpgi.00097.2012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
165 Altomare A, Guarino MPL, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol 2013; 19(39): 6523-6528 [PMID: 24151376 DOI: 10.3748/wjg.v19.i39.6523] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
166 Bühling F, Peitz U, Krüger S, Küster D, Vieth M, Gebert I, Roessner A, Weber E, Malfertheiner P, Wex T. Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa. Biol Chem. 2004;385:439-445. [PMID: 15196006 DOI: 10.1515/bc.2004.051] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
167 Salvatore S, Hauser B, Devreker T, Arrigo S, Marino P, Citro C, Salvatoni A, Vandenplas Y. Esophageal impedance and esophagitis in children: any correlation? J Pediatr Gastroenterol Nutr 2009;49:566-70. [PMID: 19820412 DOI: 10.1097/MPG.0b013e3181a23dac] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
168 Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma. Am J Gastroenterol. 2007;102:2373-2379. [PMID: 17581270 DOI: 10.1111/j.1572-0241.2007.01373.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
169 de Souza HS, Tortori CA, Lintomen L, Figueiredo RT, Bernardazzi C, Leng L, Bucala R, Madi K, Buongusto F, Elia CC, Castelo-Branco MT, Bozza MT. Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis. Mucosal Immunol 2015;8:1154-65. [PMID: 25712805 DOI: 10.1038/mi.2015.6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
170 Hartman KG, Bortner JD, Falk GW, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems. Stem Cell Res Ther 2013;4 Suppl 1:S5. [PMID: 24564965 DOI: 10.1186/scrt366] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
171 Ali I, Rafiee P, Hogan WJ, Jacob HJ, Komorowski RA, Haasler GB, Shaker R. Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls. Am J Gastroenterol 2006;101:1437-48. [PMID: 16863544 DOI: 10.1111/j.1572-0241.2006.00584.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
172 Badreddine RJ, Wang KK. Barrett esophagus: an update. Nat Rev Gastroenterol Hepatol 2010;7:369-78. [DOI: 10.1038/nrgastro.2010.78] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
173 Rajendra S, Ackroyd R, Murad S, Mohan C, Ho JJ, Goh KL, Azrena A, Too CL. Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians - a preliminary study. Aliment Pharmacol Ther 2005;21:1377-83. [DOI: 10.1111/j.1365-2036.2005.02496.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
174 Fang Y, Chen H, Hu Y, Djukic Z, Tevebaugh W, Shaheen NJ, Orlando RC, Hu J, Chen X. Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice. Am J Physiol Gastrointest Liver Physiol 2013;305:G58-65. [PMID: 23639809 DOI: 10.1152/ajpgi.00438.2012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
175 O'Sullivan KE, Hurley ET, Hurley JP. Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival. Gastroenterol Res Pract 2015;2015:518281. [PMID: 26246803 DOI: 10.1155/2015/518281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
176 Fang Y, Chen H, Hu Y, Djukic Z, Tevebaugh W, Shaheen NJ, Orlando RC, Hu J, Chen X. Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice. Am J Physiol Gastrointest Liver Physiol. 2013;305:G58-G65. [PMID: 23639809 DOI: 10.1152/ajpgi.00438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Fofaria RK, Morris DL. Hiatus hernia and gastro-oesophageal reflux disease. Medicine 2015;43:192-6. [DOI: 10.1016/j.mpmed.2015.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Whalley B, Jacobs PA, Hyland ME. Correlation of psychological and physical symptoms with chronically elevated cytokine levels associated with a common immune dysregulation. Ann Allergy Asthma Immunol 2007;99:348-51. [PMID: 17941282 DOI: 10.1016/S1081-1206(10)60551-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
179 Borgmann M, Quante M. Impact of the Tumor Microenvironment for Esophageal Tumor Development—An Opportunity for Prevention? Cancers 2022;14:2246. [DOI: 10.3390/cancers14092246] [Reference Citation Analysis]
180 Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut. 2005;54 Suppl 1:i21-i26. [PMID: 15711004 DOI: 10.1136/gut.2004.041558] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]